Common use of ¨ Check if Transfer is Pursuant to Other Exemption Clause in Contracts

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the Issuers. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Re: 6.00% Senior Notes due 2025 (CUSIP [G3040 E AA6]29273 E AA6) Reference is hereby made to the Indenture, dated as of January 27, 2014 (the “Indenture”), among Endo Limited, Endo Finance LLC and Endo Xxxxx Inc. (collectively, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the Issuers. [Insert Name of Transferor] By: Name: Title: Dated: Signature Guarantee*: * Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee) EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Designated Activity Company Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx XxxxxxxMalvern, Xxxxxxxxxxxx 00000 Pennsylvania 19355 Xxxxx Fargo Bank, National Association DAPS Reorg Bondholder Communications MAC N9303N9300-121 000-070 000 Xxxxx 0xx Xxxxxx Xxxxx XxxxxxxxxxxMinneapolis, Xxxxxxxxx 00000 Minnesota 55479 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Xxxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxxx.xxx Re: 6.006.000% Senior Notes due 2025 2028 (CUSIP [G3040 E AA6]29273 E AA629273D AC4; G30407 AC7) Reference is hereby made to the Indenture, dated as of January 27June 16, 2014 2020 (the “Indenture”), among Endo LimitedDesignated Activity Company, a designated activity company incorporated under the laws of Ireland (“Endo DAC”), Endo Finance LLC LLC, a Delaware limited liability company (“Endo Finance”) and Endo Xxxxx Inc. Inc., a Delaware corporation (collectively“Endo Xxxxx” and, together with Endo DAC and Endo Finance, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the IssuersCompany. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Pharmaceuticals Holdings Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx000 Xxxx Xxxxxxxxx Xxxxxx Xxxx, Xxxxxxxxxxxx XX 00000 Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Re: 6.007 1/4% Senior Notes due 2025 2022 (CUSIP [G3040 E AA6]29273 E AA6[ ]) Reference is hereby made to the Indenture, dated as of January 27June 8, 2014 2011 (the “Indenture”), among Endo LimitedPharmaceuticals Holdings Inc., Endo Finance LLC and Endo Xxxxx Inc. as issuer (collectively, the “IssuersCompany”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the IssuersIssuer. [Insert Name of Transferor] By: Name: Title: Dated: Signature Guarantee*: * Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee) EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Par Pharmaceutical, Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxx Fargo Bank, National Association DAPS Reorg [Bondholder Communications MAC N9303N9300-121 000-070 000 Xxxxx 0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Xxxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxxx.xxx] Re: 6.007.500% Senior Secured Notes due 2025 2027 (CUSIP [G3040 E AA6]29273 E AA6●]) Reference is hereby made to the Indenture, dated as of January 27March 28, 2014 2019 (the “Indenture”), among Endo LimitedPar Pharmaceutical, Endo Finance LLC and Endo Xxxxx Inc. (collectively, the “IssuersIssuer”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the IssuersIssuer. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Horizon Pharma, Inc. Horizon Pharma USA, Inc. c/o Endo Health Solutions Inc. 0000 Horizon Pharma Public Limited Company. Xxxxxxxxx Xxxxx, 0xx Xxxxx 0 Xxxxxxxxxx Xxxx Xxxxxx 0, Xxxxxxx Xxxxx Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxx Fargo Bank, U.S. Bank National Association DAPS Reorg MAC N9303Corporate Trust Services West Side Flats 00 Xxxxxxxxxx Xxxxxx St. Xxxx MN 00000-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.0000 Fax: (000) 000-0000 Facsimile No.Attention: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Xxxxxxx X. Xxxxxxxxxx Re: 6.008.750% Senior Notes due 2025 2024 (CUSIP [G3040 E AA6]29273 E AA6[ ]) Reference is hereby made to the Indenture, dated as of January 27October 25, 2014 2016 (the “Indenture”), among Endo LimitedHorizon Pharma, Endo Finance LLC and Endo Xxxxx Inc. (collectivelythe “Company), Horizon Pharma USA, Inc. (the “Co-Issuer” and, together with the Company, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, U.S. Bank National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture Warrant Certificate and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the IndentureStates. This certificate and the statements contained herein are made for your benefit and the benefit of the IssuersCompany and for the benefit of the Warrant Agent. [Insert Name of TransferorTransferee] By: Name: Title: Dated: EXHIBIT C SCHEDULE D FORM OF CERTIFICATE OF EXCHANGE Endo PUT NOTICE RELATING TO WARRANTS ISSUED BY YINGLI GREEN ENERGY HOLDING COMPANY LIMITED (THE “COMPANY”) Yingli Green Energy Holding Company Limited Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 . 3055 Middle Fuxing Road Baoding 070151 People’s Republic of China Facsimile No.: (00000) 000-000 000 0000 EmailAttention: XXXXXxxxx@xxxxxxxxxx.xxx Chief Financial Officer With a copy to: Deutsche Bank AG, Hong Kong Branch 48th Floor Xxxxxx Kong Center 0 Xxxxx’x Xxxx Xxxxxxx Xxxx Xxxx Facsimile No.: +000 0000 0000 Attention: Trust and Securities Services Re: 6.00% Senior Notes due 2025 (CUSIP [G3040 E AA6]29273 E AA6) Reference is hereby made Put Option Notice By delivering this duly completed Notice to the Indenture, dated as of January 27, 2014 (the “Indenture”), among Endo Limited, Endo Finance LLC and Endo Xxxxx Inc. (collectivelyCompany, the “Issuers”)undersigned holder of the Warrants surrendered with this Notice and referred to below irrevocably exercises its option to be paid the Put Price (as defined in, and calculated pursuant to, the Guarantors party thereto and Xxxxx Fargo Warrant Agreement) in accordance with Section 9 of the Warrant Agreement. This Notice relates to [ ___] Warrants bearing: The following serial number of Warrant Certificate(1): ISIN Number of Global Warrant(1): Payment Instructions Please make payment in respect of the above-mentioned Warrants by remittance to the following bank account: Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount : Branch Address: Branch Code: Account Number: Signature of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies thatholder: NOTES:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State state of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the IssuersCompany. [Insert Name of Transferor] By: Name: Title: Dated: ______________________ EXHIBIT C D FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo FROM ACQUIRING INSTITUTIONAL ACCREDITED INVESTOR GASTAR EXPLORATION USA, INC. 0000 Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx XxxxxxxXxxxxx, Xxxxxxxxxxxx 00000 Suite 1080 Houston, Texas 77010 Attention: Chief Financial Officer If to the Trustee: Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx0000 Xxxx Xxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 2nd Floor Dallas, Texas 75202 2812 Facsimile No.: (000) 000-0000 EmailAttention: XXXXXxxxx@xxxxxxxxxx.xxx Corporate Trust Services Re: 6.00% 12 ¾% Senior Secured Notes due 2025 (CUSIP [G3040 E AA6]29273 E AA6) 2012 Reference is hereby made to the Indenture, dated as of January 27November 29, 2014 2007 (the “Indenture”), among Endo LimitedGastar Exploration USA, Endo Finance LLC and Endo Xxxxx Inc. Inc., as issuer (collectively, the “IssuersCompany”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trusteetrustee and collateral agent. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies thatour proposed purchase of $____________ aggregate principal amount of:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the IssuersIssuer. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Claire’s Stores, Inc. 0000 Xxxx Xxxxxxx Xxxxx Xxxx Xxxxxxx Xxxxxxx, Xxxxxxxxxxxx XX 00000 Xxxxx Fargo BankFax No.: (847) 765-674 Attention: Chief Financial Officer The Bank of New York Mellon Trust Company, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx XxxxxxxxxxxN.A. 00000 Xxxxxxxxx Xxxxxxx Xxxxxxxxxxxx, Xxxxxxxxx XX 00000 Telephone Fax No.: (000) 000-0000 Facsimile No.Attention: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Corporate Trust Administration Re: 6.006.125% Senior Secured First Lien Notes due 2025 (CUSIP [G3040 E AA6]29273 E AA6) 2020 Reference is hereby made to the Indenture, dated as of January 27March 15, 2014 2013 (the “Indenture”), among Endo Limitedbetween Claire’s Stores, Endo Finance LLC and Endo Xxxxx Inc. (collectivelyInc., the “Issuers”), the Guarantors guarantors party thereto and Xxxxx Fargo BankThe Bank of New York Mellon Trust Company, National AssociationN.A., as trusteetrustee and collateral agent. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the Issuers. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Re: 6.007.00% Senior Notes due 2025 2020 (CUSIP [G3040 E AA6]29273 E AA6[ ]) Reference is hereby made to the Indenture, dated as of January 27May 6, 2014 (the “Indenture”), among Endo Limited, Endo Finance LLC and Endo Xxxxx Inc. (collectively, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the Issuers. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Re: 6.005.375% Senior Notes due 2025 2023 (CUSIP [G3040 E AA6]29273 E AA6[ ]) Reference is hereby made to the Indenture, dated as of January 27June 30, 2014 (the “Indenture”), among Endo Limited, Endo Finance LLC and Endo Xxxxx Inc. (collectively, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the Issuers. [Insert Name of Transferor] By: Name: Title: Dated: Signature Guarantee*: * Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee) EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Designated Activity Company Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx XxxxxxxMalvern, Xxxxxxxxxxxx 00000 Pennsylvania 19355 Xxxxx Fargo Bank, National Association DAPS Reorg Bondholder Communications MAC N9303N9300-121 000-070 000 Xxxxx 0xx Xxxxxx Xxxxx XxxxxxxxxxxMinneapolis, Xxxxxxxxx 00000 Minnesota 55479 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Xxxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxxx.xxx Re: 6.009.500% Senior Secured Second Lien Notes due 2025 2027 (CUSIP [G3040 E AA6]29273 E AA629273D AB6; G30407 AB9) Reference is hereby made to the Indenture, dated as of January 27June 16, 2014 2020 (the “Indenture”), among Endo LimitedDesignated Activity Company, a designated activity company incorporated under the laws of Ireland (“Endo DAC”), Endo Finance LLC LLC, a Delaware limited liability company (“Endo Finance”), and Endo Xxxxx Inc. Inc., a Delaware corporation (collectively“Endo Xxxxx” and, together with Endo DAC and Endo Finance, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the Issuers. [Insert Name of Transferor] By: Name: Title: Dated: Signature Guarantee*: * Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee) EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Designated Activity Company Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx XxxxxxxMalvern, Xxxxxxxxxxxx 00000 Pennsylvania 19355 Xxxxx Fargo Bank, National Association DAPS Reorg Bondholder Communications MAC N9303N9300-121 000-070 000 Xxxxx 0xx Xxxxxx Xxxxx XxxxxxxxxxxMinneapolis, Xxxxxxxxx 00000 Minnesota 55479 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Xxxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxxx.xxx Re: 6.005.875% Senior Secured Notes due 2025 2024 (CUSIP [G3040 E AA6]29273 E AA6●]) Reference is hereby made to the Indenture, dated as of January April 27, 2014 2017 (the “Indenture”), among Endo LimitedDesignated Activity Company, Endo Finance LLC and Endo Xxxxx Inc. (collectively, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the Issuers. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Re: 6.007.00% Senior Notes due 2025 2019 (CUSIP [G3040 E AA6]29273 E AA6[ ]) Reference is hereby made to the Indenture, dated as of January 27May 6, 2014 (the “Indenture”), among Endo Limited, Endo Finance LLC and Endo Xxxxx Inc. (collectively, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the IssuersCompany. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Pharmaceuticals Holdings Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx000 Xxxx Xxxxxxxxx Xxxxxx Xxxx, Xxxxxxxxxxxx XX 00000 Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Re: 6.007.00% Senior Notes due 2025 2020 (CUSIP [G3040 E AA6]29273 E AA6[ ]) Reference is hereby made to the Indenture, dated as of January 27November 23, 2014 2010 (the “Indenture”), among Endo LimitedPharmaceuticals Holdings Inc., Endo Finance LLC and Endo Xxxxx Inc. as issuer (collectively, the “IssuersCompany”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the Issuers. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Re: 6.007.25% Senior Notes due 2025 2022 (CUSIP [G3040 E AA6]29273 E AA6[ ]) Reference is hereby made to the Indenture, dated as of January 27May 6, 2014 (the “Indenture”), among Endo Limited, Endo Finance LLC and Endo Xxxxx Inc. (collectively, the “Issuers”), the Guarantors party thereto and Xxxxx Fargo Bank, National Association, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

¨ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. This certificate and the statements contained herein are made for your benefit and the benefit of the IssuersIssuer. [Insert Name of Transferor] By: Name: Title: Dated: EXHIBIT C FORM OF CERTIFICATE OF EXCHANGE Endo Limited Endo Finance LLC Endo GFL Environmental Inc. 000 Xxx Xxxx Xxxxx, Xxxxx Inc. c/o Endo Health Solutions Inc. 0000 Xxxxxxx Xxxxx 000 Xxxxxxx, Xxxxxxxxxxxx 00000 Xxxxxxx X0X 0X0 Xxxxxx Computershare Trust Company, N.A. 0000 Xxxxxx Xxxxxxxxx, Xxxxx Fargo Bank, National Association DAPS Reorg MAC N9303-121 000-0xx Xxxxxx Xxxxx Xxxxxxxxxxx, Xxxxxxxxx Xxxxx, XX 00000 Telephone No.Attention: (000) 000-0000 Facsimile No.: (000) 000-0000 Email: XXXXXxxxx@xxxxxxxxxx.xxx Corporate Trust Department — GFL Re: 6.00GFL Environmental Inc. 5.375% Senior Notes due 2025 (2023 CUSIP [G3040 E AA6]29273 E AA6) Reference is hereby made to the Indenture, dated as of January 27February 26, 2014 2018 (as amended, supplemented or otherwise modified from time to time, the “Indenture”), among Endo LimitedGFL Environmental Inc., Endo Finance LLC and Endo Xxxxx Inc. as issuer (collectively, the “IssuersIssuer”), the Guarantors party thereto guarantors named therein and Xxxxx Fargo BankComputershare Trust Company, National AssociationN.A., as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. , (the “Owner”) owns and proposes to exchange the Note[s] or beneficial interest in such Note[s] specified herein, in the principal amount of $ in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that: